Company Active LTD

Company profile

Reco Medical Ltd

Reco Medical LTD

Reco Medical Ltd is a UK company with status active founded in 2019 based in London.

CRN
12169122
Founded
2019
Age
6

Overview

Legal name
RECO MEDICAL LTD
Region
London
Registered address
26 PINNER VIEW
HARROW
ENGLAND
HA1 4QA
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 May
2027

Accounts due

Accounts Due

Next accounts due date

04 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Aug
2025

Accounts filed

Accounts

Last accounts made up date

21 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

02 Sep
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzNDE2MzMzMmFkaXF6a2N4

Published 02 Sep 2024 14:58

22 Aug
2019

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020, 2021, 2023, 2025
Age at first award
1 years

Projects

2025 Collaborative R&D Lead participant

Wearable Intracranial Pressure Monitoring Implant System

1 Apr 2025 to 30 Sep 2026

Awarded
£349,988
Total cost £499,983

Elevated intracranial pressure (ICP) is a critical condition resulting from severe head injuries and various neurological disorders, potentially leading to serious outcomes, including death. Monitoring ICP is crucial in neurosurgical care for both acute events like traumatic brain injury (TBI), subarachnoid hemorrhage, and intracerebral hematoma, as well ...

2023 Collaborative R&D Lead participant

An Implantable Sensor ‘LAP-Sense’ for Remote/Continuous Monitoring of Complex Cardiovascular Patients

1 May 2023 to 31 Oct 2024

Awarded
£236,420
Total cost £337,742

Every year, Cardiovascular Disease (CVD) causes 24% of all deaths worldwide or 18million/annum, with 85% of fatalities due to stroke, heart failure (HF) and atrial fibrillation (AF). The UK has over 6 million CVD sufferers, costing £7.4billion/annum in healthcare costs and £15.8billion/annum in economic losses. Traditionally, clinicians have focused on ph...

2023 Collaborative R&D Lead participant

Wireless Intracranial Pressure Monitoring System

1 Apr 2023 to 30 Sep 2024

Awarded
£349,643
Total cost £499,490

Elevated intracranial pressure (ICP) is a dangerous condition caused by severe head injuries and multiple other neurological conditions that can lead to severe neurological outcomes, including death. ICP monitoring is an extremely important part of neurosurgical care for both acute events such as traumatic brain injury (TBI), subarachnoid haemorrhage and ...

2021 Collaborative R&D Lead participant

Wireless Intracranial Pressure Monitoring System

1 Dec 2021 to 31 Jan 2022

Awarded
£66,670
Total cost £66,670

Intracranial Pressure (ICP) monitoring is an extremely important part of neurosurgical care for both acute events such as traumatic brain injury (TBI), subarachnoid hemorrhage and intracerebral hematoma as well as chronic diseases such as hydrocephalus or benign intracranial hypertension. Current wired ICP monitoring systems involve a surgical procedure, ...

2020 Study Lead participant

Wireless Intracranial Pressure Monitoring System

1 Nov 2020 to 30 Apr 2022

Awarded
£349,952
Total cost £499,932

ICP measurement and monitoring is an extremely important part of the neurosurgical care for both acute events such as traumatic brain injury (TBI), stroke and cancer patients as well as chronic diseases such as hydrocephalus or benign intracranial hypertension. Current ICP monitoring systems involve a surgical procedure - introducing an intracranial probe...

Product types

Collaborative R&D Study